Milnacipran

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 859 publications

Mind and Muscle: A Retrospective Study on the Management of Psychiatric Comorbidities in Patients With Fibromyalgia Treated With Pregabalin Versus Milnacipran.

Mind and Muscle: A Retrospective Study on the Management of Psychiatric Comorbidities in Patients With Fibromyalgia Treated With Pregabalin Versus Milnacipran.

Journal: Cureus

Published: February 06, 2026

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.

Journal: JAMA network open

Published: February 03, 2026

Milnacipran for the treatment of refractory chronic cough: a report of two cases

Milnacipran for the treatment of refractory chronic cough: a report of two cases

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Sublingual cyclobenzaprine (Tonmya) for fibromyalgia.

Sublingual cyclobenzaprine (Tonmya) for fibromyalgia.

Journal: The Medical letter on drugs and therapeutics

Published: January 08, 2026

Current pharmacological management, treatment challenges, and potential future treatment options for fibromyalgia syndrome.

Current pharmacological management, treatment challenges, and potential future treatment options for fibromyalgia syndrome.

Journal: Expert opinion on pharmacotherapy

Published: December 14, 2025

From Years of Pain to a Name: Fibromyalgia Uncovered.

From Years of Pain to a Name: Fibromyalgia Uncovered.

Journal: Cureus

Published: October 28, 2025

Good Evidence That Duloxetine, Milnacipran, and Pregabalin Provide Meaningful Pain Reduction in Adults With Fibromyalgia.

Good Evidence That Duloxetine, Milnacipran, and Pregabalin Provide Meaningful Pain Reduction in Adults With Fibromyalgia.

Journal: American family physician

Published: October 21, 2025

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Journal: BMJ open

Published: October 08, 2025

Fibromyalgia Analog Model index analysis demonstrates the predictive validity of the Dahl S rat as a model of fibromyalgia.

Fibromyalgia Analog Model index analysis demonstrates the predictive validity of the Dahl S rat as a model of fibromyalgia.

Journal: Pain

Published: October 07, 2025

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system.

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: October 07, 2025

Prediction of 12-Week Remission in Patients With Depressive Disorder Using Reasoning-Based Large Language Models: Model Development and Validation Study.

Prediction of 12-Week Remission in Patients With Depressive Disorder Using Reasoning-Based Large Language Models: Model Development and Validation Study.

Journal: JMIR mental health

Published: September 01, 2025

In Search of Molecular Correlates of Fibromyalgia: The Quest for Objective Diagnosis and Effective Treatments.

In Search of Molecular Correlates of Fibromyalgia: The Quest for Objective Diagnosis and Effective Treatments.

Journal: International journal of molecular sciences

Published: August 31, 2025

Showing 1-12 of 859

Last Updated: 04/28/2026